The assay is heat stable at ambient or elevated temperatures, bypassing the need for cold chain during transport and storage.

Elegen, a global leader in next-generation DNA manufacturing, and Nutcracker Therapeutics, a global leader in next-generation ...

Elegen, Nutcracker Therapeutics to pilot cell-free manufacturing process for RNA-based personalized cancer therapeutics: San Francisco Tuesday, July 15, 2025, 11:00 Hrs [IST] Eleg ...

Nutcracker Therapeutics and Elegen see their mission as delivering scalable and low-cost RNA manufacturing for individualized therapies.